BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 1992810)

  • 1. NMR-visible ATP and Pi in normoxic and reperfused rat hearts: a quantitative study.
    Humphrey SM; Garlick PB
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H6-12. PubMed ID: 1992810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR visibility of Pi in perfused rat hearts is affected by changes in substrate and contractility.
    Garlick PB; Townsend RM
    Am J Physiol; 1992 Aug; 263(2 Pt 2):H497-502. PubMed ID: 1510146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of perfluorochemical perfusion in the isolated working rabbit heart preparation using 31P-NMR.
    Freeman D; Mayr H; Schmidt P; Roberts JD; Bing RJ
    Biochim Biophys Acta; 1987 Mar; 927(3):350-8. PubMed ID: 3814627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in nucleotide compartmentation and energy state in isolated and in situ rat heart: assessment by 31P-NMR spectroscopy.
    Williams JP; Headrick JP
    Biochim Biophys Acta; 1996 Aug; 1276(1):71-9. PubMed ID: 8764892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graded global ischaemia and reperfusion of the isolated perfused rat heart: characterisation by 31P NMR spectroscopy of the extent of energy metabolism damage.
    Lavanchy N; Martin J; Rossi A
    Cardiovasc Res; 1984 Sep; 18(9):573-82. PubMed ID: 6467274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 31P NMR and enzymatic analysis of cytosolic phosphocreatine, ATP, Pi and intracellular pH in the isolated working perfused rat heart.
    Dobson GP; Veech RL; Passonneau JV; Kobayashi K; Inubushi T; Wehrli S; Nioka S; Chance B
    NMR Biomed; 1992; 5(1):20-8. PubMed ID: 1550706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy.
    Löster H; Keller T; Grommisch J; Gründer W
    Mol Cell Biochem; 1999 Oct; 200(1-2):93-102. PubMed ID: 10569188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NMR-invisible ATP in heart: fact or fiction?
    Bak MI; Ingwall JS
    Am J Physiol; 1992 Jun; 262(6 Pt 1):E943-7. PubMed ID: 1616027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-ischemic effects of trimetazidine: 31P-NMR spectroscopy in the isolated rat heart.
    Lavanchy N; Martin J; Rossi A
    Arch Int Pharmacodyn Ther; 1987 Mar; 286(1):97-110. PubMed ID: 3592863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy metabolism and mechanical recovery after cardioplegia in moderately hypertrophied rats.
    Smolenski RT; Jayakumar J; Seymour AM; Yacoub MH
    Mol Cell Biochem; 1998 Mar; 180(1-2):137-43. PubMed ID: 9546640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of nifedipine in myocardial ischemia assessed by phosphorus-31 nuclear magnetic resonance.
    Ruigrok TJ; van Echteld CJ; de Kruijff B; Borst C; Meijler FL
    Eur Heart J; 1983 May; 4 Suppl C():109-13. PubMed ID: 6617693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of diltiazem on the energy metabolism of the isolated rat heart submitted to ischaemia: a 31P NMR study.
    Lavanchy N; Martin J; Rossi A
    J Mol Cell Cardiol; 1986 Sep; 18(9):931-41. PubMed ID: 3783728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential in vivo measurement of cerebral intracellular metabolites with phosphorus-31 magnetic resonance spectroscopy during global cerebral ischemia and reperfusion in rats.
    Andrews BT; Weinstein PR; Keniry M; Pereira B
    Neurosurgery; 1987 Nov; 21(5):699-708. PubMed ID: 3696405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting functional recovery from ischemia in the rat myocardium.
    Jeffrey FM; Storey CJ; Malloy CR
    Basic Res Cardiol; 1992; 87(6):548-58. PubMed ID: 1485887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NMR-invisible ATP in rat heart and its change in ischemia.
    Takami H; Furuya E; Tagawa K; Seo Y; Murakami M; Watari H; Matsuda H; Hirose H; Kawashima Y
    J Biochem; 1988 Jul; 104(1):35-9. PubMed ID: 3220828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Creatine and cyclocreatine effects on ischemic myocardium: 31P nuclear magnetic resonance evaluation of intact heart.
    Osbakken M; Ito K; Zhang D; Ponomarenko I; Ivanics T; Jahngen EG; Cohn M
    Cardiology; 1992; 80(3-4):184-95. PubMed ID: 1511465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine antagonism decreases metabolic but not functional recovery from ischemia.
    Angello DA; Headrick JP; Coddington NM; Berne RM
    Am J Physiol; 1991 Jan; 260(1 Pt 2):H193-200. PubMed ID: 1992797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained function of normoxic hearts depleted in ATP and phosphocreatine: a 31P-NMR study.
    Hoerter JA; Lauer C; Vassort G; Guéron M
    Am J Physiol; 1988 Aug; 255(2 Pt 1):C192-201. PubMed ID: 3407764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphocreatine restores high-energy phosphates in ischemic myocardium: implication for off-pump cardiac revascularization.
    Prabhakar G; Vona-Davis L; Murray D; Lakhani P; Murray G
    J Am Coll Surg; 2003 Nov; 197(5):786-91. PubMed ID: 14585415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone pretreatment effects on ischemic isovolumic rat hearts: a P-31 nuclear magnetic resonance study of intracellular pH and high-energy phosphates contents evolutions.
    Vander Elst L; Goudemant JF; Mouton J; Chatelain P; Van Haverbeke Y; Muller RN
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):377-85. PubMed ID: 1691360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.